Leo Osprey Limited
Records under this name other than patents Leo Osprey Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,821,927 | Pharmaceutical Composition now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 9,278,099 | Pazopanib Formulation now held by Novartis AG In force · High confidence | In force | High confidence | |
| US 7,829,297 | Treatment of Cancers Expressing P95 ERBB2 now held by Novartis AG Term ended Term ended Aug 2, 2024 · High confidence | Term ended | Term ended Aug 2, 2024 | High confidence |
| US 7,105,530 | Pyrimidineamines as Angiogenesis Modulators now held by Novartis AG Term ended Term ended Oct 19, 2023 · High confidence | Term ended | Term ended Oct 19, 2023 | High confidence |
| US 7,141,576 | Cancer Treatment Method now held by Novartis AG Term ended Term ended Mar 10, 2022 · High confidence | Term ended | Term ended Mar 10, 2022 | High confidence |
| US 8,444,988 | Cancer Treatment Method now held by Novartis AG Term ended Term ended Jan 14, 2022 · Medium confidence | Term ended | Term ended Jan 14, 2022 | Medium confidence |
| US 7,262,203 | Pyrimidineamines as Angiogenesis Modulators now held by Novartis AG Term ended Ended no later than Dec 19, 2021 · Medium confidence | Term ended | Ended no later than Dec 19, 2021 | Medium confidence |
| US 7,858,626 | Pyrimidineamines as Angiogenesis Modulators now held by Novartis AG Term ended Term ended Dec 19, 2021 · High confidence | Term ended | Term ended Dec 19, 2021 | High confidence |
| US 8,114,885 | Chemical Compounds now held by Novartis AG Term ended Ended no later than Dec 19, 2021 · Medium confidence | Term ended | Ended no later than Dec 19, 2021 | Medium confidence |
| US 7,157,466 | Quinazoline Ditosylate Salt Compounds now held by Novartis AG Term ended Term ended Nov 19, 2021 · High confidence | Term ended | Term ended Nov 19, 2021 | High confidence |